The Nomination Committee proposes two new members to the Biothetec Board of Directors

Biodegradable orthopedic implants develop Bioretecin Shareholders’ Nomination Committee proposes that the Board be elected as a new member of the Technology Antti Vasara and a doctor of medicine Justin Barad.

It is proposed to re -elect a current board of directors Michael Piccirilloa, Sarah van Hellenberg Hubar-Fisheria, Päivi Malista and Gustav Poutiainen.

The Top of the Board of Directors currently sitting tNumminen has stated that there is no longer available for the Board of Directors, the bulletin writes.

The Board of the Stock Exchange company influences the company’s large lines and appoints and separates the CEO. In many listed companies, the Board of Directors is elected by the Nomination Committee, which is usually designated by the largest owners.

The BioRetec Nomination Committee had Poutiainen, who is also chairman of the company’s board of directors, which is also Stephen Industriesin chairman. From Ilmarinen The representative of the responsible investment was represented Karoliina Lindroos and investment manager from the University of Helsinki Marko Berg.

The largest owner of BioRetec is Stephen Industries with 10.95 %. Ilmarinen owns 7.50 percent, Evlin Fund 4.30 % and University of Helsinki 3.93 per cent.